nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—AGTR1—breast cancer	0.21	0.566	CbGaD
Telmisartan—ABCG2—breast cancer	0.114	0.307	CbGaD
Telmisartan—ABCB1—breast cancer	0.0474	0.128	CbGaD
Telmisartan—SLCO1B3—Paclitaxel—breast cancer	0.0287	0.077	CbGbCtD
Telmisartan—SLCO1B3—Docetaxel—breast cancer	0.0208	0.0557	CbGbCtD
Telmisartan—ABCC2—Tamoxifen—breast cancer	0.0189	0.0506	CbGbCtD
Telmisartan—ABCG2—Tamoxifen—breast cancer	0.0171	0.0458	CbGbCtD
Telmisartan—ABCB1—Toremifene—breast cancer	0.0169	0.0452	CbGbCtD
Telmisartan—ABCG2—Mitoxantrone—breast cancer	0.0166	0.0446	CbGbCtD
Telmisartan—CYP2C19—Lapatinib—breast cancer	0.0152	0.0409	CbGbCtD
Telmisartan—SLCO1B3—Methotrexate—breast cancer	0.015	0.0402	CbGbCtD
Telmisartan—ABCC2—Paclitaxel—breast cancer	0.0147	0.0394	CbGbCtD
Telmisartan—ABCC2—Irinotecan—breast cancer	0.0145	0.0389	CbGbCtD
Telmisartan—ABCC2—Carboplatin—breast cancer	0.0138	0.0371	CbGbCtD
Telmisartan—ABCG2—Paclitaxel—breast cancer	0.0133	0.0356	CbGbCtD
Telmisartan—ABCG2—Irinotecan—breast cancer	0.0131	0.0351	CbGbCtD
Telmisartan—ABCC2—Vinblastine—breast cancer	0.0129	0.0346	CbGbCtD
Telmisartan—ABCG2—Fluorouracil—breast cancer	0.0126	0.0337	CbGbCtD
Telmisartan—ABCG2—Carboplatin—breast cancer	0.0125	0.0335	CbGbCtD
Telmisartan—ABCB1—Lapatinib—breast cancer	0.0123	0.033	CbGbCtD
Telmisartan—ABCC2—Docetaxel—breast cancer	0.0106	0.0285	CbGbCtD
Telmisartan—ABCG2—Docetaxel—breast cancer	0.00961	0.0258	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—breast cancer	0.00792	0.0212	CbGbCtD
Telmisartan—ABCC2—Methotrexate—breast cancer	0.00767	0.0206	CbGbCtD
Telmisartan—CYP2C19—Tamoxifen—breast cancer	0.00763	0.0205	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—breast cancer	0.00716	0.0192	CbGbCtD
Telmisartan—ABCG2—Methotrexate—breast cancer	0.00694	0.0186	CbGbCtD
Telmisartan—ABCB1—Vinorelbine—breast cancer	0.00682	0.0183	CbGbCtD
Telmisartan—ABCB1—Tamoxifen—breast cancer	0.00616	0.0165	CbGbCtD
Telmisartan—ABCB1—Mitoxantrone—breast cancer	0.006	0.0161	CbGbCtD
Telmisartan—ABCB1—Gemcitabine—breast cancer	0.0053	0.0142	CbGbCtD
Telmisartan—ABCB1—Paclitaxel—breast cancer	0.00479	0.0128	CbGbCtD
Telmisartan—ABCB1—Irinotecan—breast cancer	0.00473	0.0127	CbGbCtD
Telmisartan—ABCB1—Vinblastine—breast cancer	0.0042	0.0113	CbGbCtD
Telmisartan—ABCB1—Docetaxel—breast cancer	0.00346	0.00929	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—breast cancer	0.00258	0.00692	CbGbCtD
Telmisartan—ABCB1—Methotrexate—breast cancer	0.0025	0.00671	CbGbCtD
Telmisartan—PPARG—Topotecan—Irinotecan—breast cancer	0.00165	1	CbGdCrCtD
Telmisartan—Azilsartan medoxomil—AGTR1—breast cancer	0.001	0.272	CrCbGaD
Telmisartan—AGTR1—nipple—breast cancer	0.000992	0.0557	CbGeAlD
Telmisartan—PPARG—mammary gland—breast cancer	0.000986	0.0554	CbGeAlD
Telmisartan—SLCO1B3—pituitary gland—breast cancer	0.000893	0.0502	CbGeAlD
Telmisartan—PPARG—nipple—breast cancer	0.000815	0.0458	CbGeAlD
Telmisartan—SLCO1B3—endocrine gland—breast cancer	0.000692	0.0389	CbGeAlD
Telmisartan—PPARG—embryo—breast cancer	0.000673	0.0378	CbGeAlD
Telmisartan—AGTR1—epithelium—breast cancer	0.000668	0.0375	CbGeAlD
Telmisartan—Olmesartan—SLCO1B1—breast cancer	0.000593	0.161	CrCbGaD
Telmisartan—PPARG—epithelium—breast cancer	0.000549	0.0308	CbGeAlD
Telmisartan—AGTR1—pituitary gland—breast cancer	0.000542	0.0304	CbGeAlD
Telmisartan—AGTR1—adipose tissue—breast cancer	0.00054	0.0303	CbGeAlD
Telmisartan—PPARG—skin of body—breast cancer	0.000522	0.0293	CbGeAlD
Telmisartan—AGTR1—female reproductive system—breast cancer	0.000496	0.0279	CbGeAlD
Telmisartan—AGTR1—adrenal gland—breast cancer	0.000484	0.0272	CbGeAlD
Telmisartan—Olmesartan—AGTR1—breast cancer	0.000476	0.129	CrCbGaD
Telmisartan—PPARG—uterus—breast cancer	0.000454	0.0255	CbGeAlD
Telmisartan—PPARG—adipose tissue—breast cancer	0.000444	0.0249	CbGeAlD
Telmisartan—AGTR1—endocrine gland—breast cancer	0.00042	0.0236	CbGeAlD
Telmisartan—PPARG—female reproductive system—breast cancer	0.000408	0.0229	CbGeAlD
Telmisartan—PPARG—adrenal gland—breast cancer	0.000398	0.0224	CbGeAlD
Telmisartan—PPARG—bone marrow—breast cancer	0.000385	0.0216	CbGeAlD
Telmisartan—PPARG—female gonad—breast cancer	0.000371	0.0209	CbGeAlD
Telmisartan—Candesartan—AGTR1—breast cancer	0.00037	0.101	CrCbGaD
Telmisartan—ABCC2—female reproductive system—breast cancer	0.000358	0.0201	CbGeAlD
Telmisartan—ABCC2—adrenal gland—breast cancer	0.00035	0.0197	CbGeAlD
Telmisartan—PPARG—endocrine gland—breast cancer	0.000345	0.0194	CbGeAlD
Telmisartan—ABCG2—endometrium—breast cancer	0.000316	0.0177	CbGeAlD
Telmisartan—ABCC2—endocrine gland—breast cancer	0.000303	0.017	CbGeAlD
Telmisartan—Losartan—SLCO1B1—breast cancer	0.000297	0.0809	CrCbGaD
Telmisartan—ABCG2—uterus—breast cancer	0.000291	0.0163	CbGeAlD
Telmisartan—AGTR1—lymph node—breast cancer	0.00029	0.0163	CbGeAlD
Telmisartan—ABCG2—pituitary gland—breast cancer	0.000286	0.016	CbGeAlD
Telmisartan—ABCG2—adipose tissue—breast cancer	0.000284	0.016	CbGeAlD
Telmisartan—Deferasirox—CYP3A4—breast cancer	0.000271	0.0738	CrCbGaD
Telmisartan—CYP2C19—endocrine gland—breast cancer	0.000261	0.0146	CbGeAlD
Telmisartan—ABCG2—adrenal gland—breast cancer	0.000255	0.0143	CbGeAlD
Telmisartan—ABCG2—bone marrow—breast cancer	0.000247	0.0139	CbGeAlD
Telmisartan—PPARG—lymph node—breast cancer	0.000239	0.0134	CbGeAlD
Telmisartan—Losartan—AGTR1—breast cancer	0.000238	0.0648	CrCbGaD
Telmisartan—ABCG2—female gonad—breast cancer	0.000238	0.0134	CbGeAlD
Telmisartan—ABCB1—embryo—breast cancer	0.000213	0.0119	CbGeAlD
Telmisartan—ABCC2—lymph node—breast cancer	0.00021	0.0118	CbGeAlD
Telmisartan—ABCB1—epithelium—breast cancer	0.000174	0.00975	CbGeAlD
Telmisartan—Candesartan—PTGS1—breast cancer	0.000172	0.0468	CrCbGaD
Telmisartan—ABCB1—endometrium—breast cancer	0.000156	0.00874	CbGeAlD
Telmisartan—ABCG2—lymph node—breast cancer	0.000153	0.00859	CbGeAlD
Telmisartan—ABCB1—uterus—breast cancer	0.000143	0.00806	CbGeAlD
Telmisartan—ABCB1—pituitary gland—breast cancer	0.000141	0.00791	CbGeAlD
Telmisartan—ABCB1—adipose tissue—breast cancer	0.00014	0.00788	CbGeAlD
Telmisartan—ABCB1—female reproductive system—breast cancer	0.000129	0.00724	CbGeAlD
Telmisartan—ABCB1—adrenal gland—breast cancer	0.000126	0.00707	CbGeAlD
Telmisartan—ABCB1—bone marrow—breast cancer	0.000122	0.00684	CbGeAlD
Telmisartan—ABCB1—female gonad—breast cancer	0.000117	0.00659	CbGeAlD
Telmisartan—ABCB1—endocrine gland—breast cancer	0.000109	0.00613	CbGeAlD
Telmisartan—Candesartan—ABCB1—breast cancer	8.36e-05	0.0227	CrCbGaD
Telmisartan—ABCB1—lymph node—breast cancer	7.54e-05	0.00424	CbGeAlD
Telmisartan—Losartan—CYP3A4—breast cancer	6.47e-05	0.0176	CrCbGaD
Telmisartan—Losartan—ALB—breast cancer	5.65e-05	0.0153	CrCbGaD
Telmisartan—Losartan—ABCB1—breast cancer	5.39e-05	0.0146	CrCbGaD
Telmisartan—Insomnia—Capecitabine—breast cancer	2.39e-05	0.000158	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—breast cancer	2.38e-05	0.000157	CcSEcCtD
Telmisartan—Rash—Fluorouracil—breast cancer	2.38e-05	0.000157	CcSEcCtD
Telmisartan—Dermatitis—Fluorouracil—breast cancer	2.38e-05	0.000157	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—breast cancer	2.38e-05	0.000157	CcSEcCtD
Telmisartan—Paraesthesia—Capecitabine—breast cancer	2.37e-05	0.000156	CcSEcCtD
Telmisartan—Decreased appetite—Docetaxel—breast cancer	2.37e-05	0.000156	CcSEcCtD
Telmisartan—Hypersensitivity—Paclitaxel—breast cancer	2.37e-05	0.000156	CcSEcCtD
Telmisartan—Headache—Fluorouracil—breast cancer	2.37e-05	0.000156	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—breast cancer	2.37e-05	0.000156	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—breast cancer	2.36e-05	0.000156	CcSEcCtD
Telmisartan—Dysgeusia—Methotrexate—breast cancer	2.36e-05	0.000156	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Docetaxel—breast cancer	2.36e-05	0.000155	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—breast cancer	2.36e-05	0.000155	CcSEcCtD
Telmisartan—Dyspnoea—Capecitabine—breast cancer	2.35e-05	0.000155	CcSEcCtD
Telmisartan—Fatigue—Docetaxel—breast cancer	2.35e-05	0.000155	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—breast cancer	2.35e-05	0.000155	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—breast cancer	2.35e-05	0.000155	CcSEcCtD
Telmisartan—Nausea—Mitoxantrone—breast cancer	2.34e-05	0.000155	CcSEcCtD
Telmisartan—Nausea—Irinotecan—breast cancer	2.34e-05	0.000155	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—breast cancer	2.34e-05	0.000154	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—breast cancer	2.33e-05	0.000154	CcSEcCtD
Telmisartan—Pain—Docetaxel—breast cancer	2.33e-05	0.000154	CcSEcCtD
Telmisartan—Constipation—Docetaxel—breast cancer	2.33e-05	0.000154	CcSEcCtD
Telmisartan—Back pain—Methotrexate—breast cancer	2.33e-05	0.000154	CcSEcCtD
Telmisartan—Dyspepsia—Capecitabine—breast cancer	2.33e-05	0.000153	CcSEcCtD
Telmisartan—Chills—Epirubicin—breast cancer	2.32e-05	0.000153	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—breast cancer	2.31e-05	0.000153	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—breast cancer	2.31e-05	0.000152	CcSEcCtD
Telmisartan—Asthenia—Paclitaxel—breast cancer	2.31e-05	0.000152	CcSEcCtD
Telmisartan—Decreased appetite—Capecitabine—breast cancer	2.3e-05	0.000151	CcSEcCtD
Telmisartan—Nausea—Gemcitabine—breast cancer	2.28e-05	0.000151	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Capecitabine—breast cancer	2.28e-05	0.00015	CcSEcCtD
Telmisartan—Fatigue—Capecitabine—breast cancer	2.28e-05	0.00015	CcSEcCtD
Telmisartan—Pruritus—Paclitaxel—breast cancer	2.28e-05	0.00015	CcSEcCtD
Telmisartan—Mental disorder—Epirubicin—breast cancer	2.27e-05	0.00015	CcSEcCtD
Telmisartan—Constipation—Capecitabine—breast cancer	2.26e-05	0.000149	CcSEcCtD
Telmisartan—Pain—Capecitabine—breast cancer	2.26e-05	0.000149	CcSEcCtD
Telmisartan—Erythema—Epirubicin—breast cancer	2.25e-05	0.000149	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—breast cancer	2.25e-05	0.000149	CcSEcCtD
Telmisartan—Feeling abnormal—Docetaxel—breast cancer	2.25e-05	0.000148	CcSEcCtD
Telmisartan—Nausea—Fluorouracil—breast cancer	2.25e-05	0.000148	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—breast cancer	2.24e-05	0.000148	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—breast cancer	2.24e-05	0.000147	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—breast cancer	2.23e-05	0.000147	CcSEcCtD
Telmisartan—Gastrointestinal pain—Docetaxel—breast cancer	2.23e-05	0.000147	CcSEcCtD
Telmisartan—Anaemia—Methotrexate—breast cancer	2.23e-05	0.000147	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—breast cancer	2.22e-05	0.000147	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—breast cancer	2.22e-05	0.000147	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—breast cancer	2.22e-05	0.000147	CcSEcCtD
Telmisartan—Tension—Epirubicin—breast cancer	2.21e-05	0.000146	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—breast cancer	2.21e-05	0.000146	CcSEcCtD
Telmisartan—Diarrhoea—Paclitaxel—breast cancer	2.2e-05	0.000145	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—breast cancer	2.19e-05	0.000144	CcSEcCtD
Telmisartan—Back pain—Epirubicin—breast cancer	2.18e-05	0.000144	CcSEcCtD
Telmisartan—Feeling abnormal—Capecitabine—breast cancer	2.18e-05	0.000144	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—breast cancer	2.17e-05	0.000143	CcSEcCtD
Telmisartan—Malaise—Methotrexate—breast cancer	2.17e-05	0.000143	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—breast cancer	2.17e-05	0.000143	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—breast cancer	2.16e-05	0.000143	CcSEcCtD
Telmisartan—Vertigo—Methotrexate—breast cancer	2.16e-05	0.000143	CcSEcCtD
Telmisartan—Gastrointestinal pain—Capecitabine—breast cancer	2.16e-05	0.000142	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—breast cancer	2.16e-05	0.000142	CcSEcCtD
Telmisartan—Body temperature increased—Docetaxel—breast cancer	2.16e-05	0.000142	CcSEcCtD
Telmisartan—Abdominal pain—Docetaxel—breast cancer	2.16e-05	0.000142	CcSEcCtD
Telmisartan—Chills—Doxorubicin—breast cancer	2.15e-05	0.000142	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—breast cancer	2.14e-05	0.000141	CcSEcCtD
Telmisartan—Dizziness—Paclitaxel—breast cancer	2.13e-05	0.00014	CcSEcCtD
Telmisartan—Cough—Methotrexate—breast cancer	2.1e-05	0.000139	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—breast cancer	2.1e-05	0.000139	CcSEcCtD
Telmisartan—Urticaria—Capecitabine—breast cancer	2.1e-05	0.000138	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—breast cancer	2.09e-05	0.000138	CcSEcCtD
Telmisartan—Abdominal pain—Capecitabine—breast cancer	2.09e-05	0.000138	CcSEcCtD
Telmisartan—Body temperature increased—Capecitabine—breast cancer	2.09e-05	0.000138	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—breast cancer	2.09e-05	0.000138	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—breast cancer	2.09e-05	0.000138	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—breast cancer	2.08e-05	0.000137	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—breast cancer	2.06e-05	0.000136	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—breast cancer	2.05e-05	0.000135	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—breast cancer	2.05e-05	0.000135	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—breast cancer	2.05e-05	0.000135	CcSEcCtD
Telmisartan—Tension—Doxorubicin—breast cancer	2.05e-05	0.000135	CcSEcCtD
Telmisartan—Vomiting—Paclitaxel—breast cancer	2.05e-05	0.000135	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—breast cancer	2.04e-05	0.000135	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.04e-05	0.000134	CcSEcCtD
Telmisartan—Malaise—Epirubicin—breast cancer	2.03e-05	0.000134	CcSEcCtD
Telmisartan—Rash—Paclitaxel—breast cancer	2.03e-05	0.000134	CcSEcCtD
Telmisartan—Dermatitis—Paclitaxel—breast cancer	2.03e-05	0.000134	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—breast cancer	2.03e-05	0.000134	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—breast cancer	2.03e-05	0.000134	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—breast cancer	2.03e-05	0.000134	CcSEcCtD
Telmisartan—Syncope—Epirubicin—breast cancer	2.02e-05	0.000133	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—breast cancer	2.02e-05	0.000133	CcSEcCtD
Telmisartan—Headache—Paclitaxel—breast cancer	2.02e-05	0.000133	CcSEcCtD
Telmisartan—Hypersensitivity—Docetaxel—breast cancer	2.01e-05	0.000133	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—breast cancer	2.01e-05	0.000132	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—breast cancer	1.99e-05	0.000131	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—breast cancer	1.98e-05	0.000131	CcSEcCtD
Telmisartan—Cough—Epirubicin—breast cancer	1.97e-05	0.00013	CcSEcCtD
Telmisartan—Anaphylactic shock—Methotrexate—breast cancer	1.97e-05	0.00013	CcSEcCtD
Telmisartan—Asthenia—Docetaxel—breast cancer	1.96e-05	0.000129	CcSEcCtD
Telmisartan—Infection—Methotrexate—breast cancer	1.95e-05	0.000129	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—breast cancer	1.95e-05	0.000128	CcSEcCtD
Telmisartan—Hypersensitivity—Capecitabine—breast cancer	1.95e-05	0.000128	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—breast cancer	1.94e-05	0.000128	CcSEcCtD
Telmisartan—Pruritus—Docetaxel—breast cancer	1.93e-05	0.000127	CcSEcCtD
Telmisartan—Nervous system disorder—Methotrexate—breast cancer	1.93e-05	0.000127	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—breast cancer	1.93e-05	0.000127	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—breast cancer	1.93e-05	0.000127	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—breast cancer	1.92e-05	0.000127	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—breast cancer	1.92e-05	0.000127	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—breast cancer	1.92e-05	0.000127	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—breast cancer	1.91e-05	0.000126	CcSEcCtD
Telmisartan—Nausea—Paclitaxel—breast cancer	1.91e-05	0.000126	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—breast cancer	1.91e-05	0.000126	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.91e-05	0.000126	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—breast cancer	1.9e-05	0.000125	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—breast cancer	1.9e-05	0.000125	CcSEcCtD
Telmisartan—Asthenia—Capecitabine—breast cancer	1.9e-05	0.000125	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—breast cancer	1.88e-05	0.000124	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—breast cancer	1.88e-05	0.000124	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—breast cancer	1.87e-05	0.000124	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—breast cancer	1.87e-05	0.000124	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—breast cancer	1.87e-05	0.000123	CcSEcCtD
Telmisartan—Pruritus—Capecitabine—breast cancer	1.87e-05	0.000123	CcSEcCtD
Telmisartan—Diarrhoea—Docetaxel—breast cancer	1.87e-05	0.000123	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—breast cancer	1.84e-05	0.000122	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—breast cancer	1.84e-05	0.000121	CcSEcCtD
Telmisartan—Oedema—Epirubicin—breast cancer	1.84e-05	0.000121	CcSEcCtD
Telmisartan—Hypotension—Methotrexate—breast cancer	1.84e-05	0.000121	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—breast cancer	1.83e-05	0.000121	CcSEcCtD
Telmisartan—Infection—Epirubicin—breast cancer	1.83e-05	0.000121	CcSEcCtD
Telmisartan—Cough—Doxorubicin—breast cancer	1.82e-05	0.00012	CcSEcCtD
Telmisartan—Shock—Epirubicin—breast cancer	1.81e-05	0.000119	CcSEcCtD
Telmisartan—Diarrhoea—Capecitabine—breast cancer	1.81e-05	0.000119	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—breast cancer	1.8e-05	0.000119	CcSEcCtD
Telmisartan—Dizziness—Docetaxel—breast cancer	1.8e-05	0.000119	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—breast cancer	1.8e-05	0.000119	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—breast cancer	1.8e-05	0.000119	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—breast cancer	1.8e-05	0.000118	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methotrexate—breast cancer	1.79e-05	0.000118	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—breast cancer	1.79e-05	0.000118	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—breast cancer	1.78e-05	0.000117	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—breast cancer	1.78e-05	0.000117	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—breast cancer	1.78e-05	0.000117	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—breast cancer	1.78e-05	0.000117	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—breast cancer	1.78e-05	0.000117	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—breast cancer	1.77e-05	0.000117	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—breast cancer	1.77e-05	0.000116	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.76e-05	0.000116	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—breast cancer	1.75e-05	0.000116	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—breast cancer	1.75e-05	0.000116	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—breast cancer	1.75e-05	0.000116	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—breast cancer	1.75e-05	0.000115	CcSEcCtD
Telmisartan—Dizziness—Capecitabine—breast cancer	1.75e-05	0.000115	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—breast cancer	1.74e-05	0.000115	CcSEcCtD
Telmisartan—Vomiting—Docetaxel—breast cancer	1.73e-05	0.000114	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—breast cancer	1.73e-05	0.000114	CcSEcCtD
Telmisartan—Rash—Docetaxel—breast cancer	1.72e-05	0.000113	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—breast cancer	1.72e-05	0.000113	CcSEcCtD
Telmisartan—Dermatitis—Docetaxel—breast cancer	1.72e-05	0.000113	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—breast cancer	1.71e-05	0.000113	CcSEcCtD
Telmisartan—Headache—Docetaxel—breast cancer	1.71e-05	0.000113	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—breast cancer	1.7e-05	0.000112	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—breast cancer	1.7e-05	0.000112	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Methotrexate—breast cancer	1.7e-05	0.000112	CcSEcCtD
Telmisartan—Fatigue—Methotrexate—breast cancer	1.7e-05	0.000112	CcSEcCtD
Telmisartan—Infection—Doxorubicin—breast cancer	1.69e-05	0.000112	CcSEcCtD
Telmisartan—Pain—Methotrexate—breast cancer	1.68e-05	0.000111	CcSEcCtD
Telmisartan—Vomiting—Capecitabine—breast cancer	1.68e-05	0.000111	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—breast cancer	1.68e-05	0.000111	CcSEcCtD
Telmisartan—Shock—Doxorubicin—breast cancer	1.68e-05	0.000111	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—breast cancer	1.67e-05	0.00011	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—breast cancer	1.67e-05	0.00011	CcSEcCtD
Telmisartan—Rash—Capecitabine—breast cancer	1.67e-05	0.00011	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—breast cancer	1.66e-05	0.00011	CcSEcCtD
Telmisartan—Dermatitis—Capecitabine—breast cancer	1.66e-05	0.00011	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—breast cancer	1.66e-05	0.00011	CcSEcCtD
Telmisartan—Headache—Capecitabine—breast cancer	1.65e-05	0.000109	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—breast cancer	1.65e-05	0.000109	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—breast cancer	1.65e-05	0.000109	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—breast cancer	1.65e-05	0.000109	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—breast cancer	1.64e-05	0.000108	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—breast cancer	1.64e-05	0.000108	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—breast cancer	1.62e-05	0.000107	CcSEcCtD
Telmisartan—Nausea—Docetaxel—breast cancer	1.62e-05	0.000107	CcSEcCtD
Telmisartan—Feeling abnormal—Methotrexate—breast cancer	1.62e-05	0.000107	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—breast cancer	1.62e-05	0.000107	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—breast cancer	1.61e-05	0.000106	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—breast cancer	1.6e-05	0.000106	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—breast cancer	1.59e-05	0.000105	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—breast cancer	1.59e-05	0.000105	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—breast cancer	1.59e-05	0.000105	CcSEcCtD
Telmisartan—Pain—Epirubicin—breast cancer	1.57e-05	0.000104	CcSEcCtD
Telmisartan—Constipation—Epirubicin—breast cancer	1.57e-05	0.000104	CcSEcCtD
Telmisartan—Nausea—Capecitabine—breast cancer	1.57e-05	0.000104	CcSEcCtD
Telmisartan—Urticaria—Methotrexate—breast cancer	1.56e-05	0.000103	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—breast cancer	1.55e-05	0.000103	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—breast cancer	1.55e-05	0.000103	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.55e-05	0.000102	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—breast cancer	1.54e-05	0.000102	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—breast cancer	1.53e-05	0.000101	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—breast cancer	1.52e-05	0.0001	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—breast cancer	1.52e-05	0.0001	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—breast cancer	1.51e-05	9.99e-05	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—breast cancer	1.5e-05	9.93e-05	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—breast cancer	1.5e-05	9.89e-05	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—breast cancer	1.48e-05	9.76e-05	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—breast cancer	1.47e-05	9.7e-05	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—breast cancer	1.47e-05	9.68e-05	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—breast cancer	1.46e-05	9.64e-05	CcSEcCtD
Telmisartan—Pain—Doxorubicin—breast cancer	1.46e-05	9.61e-05	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—breast cancer	1.46e-05	9.61e-05	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—breast cancer	1.45e-05	9.6e-05	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—breast cancer	1.45e-05	9.6e-05	CcSEcCtD
Telmisartan—Hypersensitivity—Methotrexate—breast cancer	1.45e-05	9.56e-05	CcSEcCtD
Telmisartan—Asthenia—Methotrexate—breast cancer	1.41e-05	9.31e-05	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—breast cancer	1.4e-05	9.26e-05	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—breast cancer	1.39e-05	9.18e-05	CcSEcCtD
Telmisartan—Pruritus—Methotrexate—breast cancer	1.39e-05	9.18e-05	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—breast cancer	1.36e-05	8.94e-05	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—breast cancer	1.35e-05	8.92e-05	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—breast cancer	1.35e-05	8.88e-05	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—breast cancer	1.35e-05	8.88e-05	CcSEcCtD
Telmisartan—Diarrhoea—Methotrexate—breast cancer	1.35e-05	8.88e-05	CcSEcCtD
Telmisartan—Asthenia—Epirubicin—breast cancer	1.32e-05	8.71e-05	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—breast cancer	1.3e-05	8.59e-05	CcSEcCtD
Telmisartan—Dizziness—Methotrexate—breast cancer	1.3e-05	8.58e-05	CcSEcCtD
Telmisartan—Diarrhoea—Epirubicin—breast cancer	1.26e-05	8.31e-05	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—breast cancer	1.25e-05	8.28e-05	CcSEcCtD
Telmisartan—Vomiting—Methotrexate—breast cancer	1.25e-05	8.25e-05	CcSEcCtD
Telmisartan—Rash—Methotrexate—breast cancer	1.24e-05	8.18e-05	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—breast cancer	1.24e-05	8.17e-05	CcSEcCtD
Telmisartan—Headache—Methotrexate—breast cancer	1.23e-05	8.13e-05	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—breast cancer	1.22e-05	8.06e-05	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—breast cancer	1.22e-05	8.03e-05	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—breast cancer	1.2e-05	7.95e-05	CcSEcCtD
Telmisartan—Vomiting—Epirubicin—breast cancer	1.17e-05	7.72e-05	CcSEcCtD
Telmisartan—Nausea—Methotrexate—breast cancer	1.17e-05	7.71e-05	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—breast cancer	1.16e-05	7.69e-05	CcSEcCtD
Telmisartan—Rash—Epirubicin—breast cancer	1.16e-05	7.65e-05	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—breast cancer	1.16e-05	7.65e-05	CcSEcCtD
Telmisartan—Headache—Epirubicin—breast cancer	1.15e-05	7.6e-05	CcSEcCtD
Telmisartan—Dizziness—Doxorubicin—breast cancer	1.13e-05	7.43e-05	CcSEcCtD
Telmisartan—Nausea—Epirubicin—breast cancer	1.09e-05	7.21e-05	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—breast cancer	1.08e-05	7.14e-05	CcSEcCtD
Telmisartan—Rash—Doxorubicin—breast cancer	1.07e-05	7.08e-05	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—breast cancer	1.07e-05	7.08e-05	CcSEcCtD
Telmisartan—Headache—Doxorubicin—breast cancer	1.07e-05	7.04e-05	CcSEcCtD
Telmisartan—Nausea—Doxorubicin—breast cancer	1.01e-05	6.67e-05	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—KDR—breast cancer	5.48e-06	6.75e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	5.47e-06	6.73e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HSP90AA1—breast cancer	5.41e-06	6.67e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	5.39e-06	6.64e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTHFR—breast cancer	5.35e-06	6.59e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ESR1—breast cancer	5.34e-06	6.58e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA9—breast cancer	5.32e-06	6.56e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA4—breast cancer	5.32e-06	6.56e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FN1—breast cancer	5.27e-06	6.49e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CG—breast cancer	5.27e-06	6.49e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NCOA1—breast cancer	5.27e-06	6.48e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	5.26e-06	6.47e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	5.24e-06	6.45e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	5.23e-06	6.44e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NFKBIA—breast cancer	5.21e-06	6.42e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	5.2e-06	6.41e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA9—breast cancer	5.2e-06	6.4e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA4—breast cancer	5.2e-06	6.4e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—STK11—breast cancer	5.19e-06	6.39e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP19A1—breast cancer	5.19e-06	6.39e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPX2—breast cancer	5.19e-06	6.39e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA2—breast cancer	5.19e-06	6.39e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH1—breast cancer	5.16e-06	6.36e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	5.13e-06	6.31e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPX4—breast cancer	5.12e-06	6.31e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SULT1A1—breast cancer	5.12e-06	6.31e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPX2—breast cancer	5.06e-06	6.24e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA2—breast cancer	5.06e-06	6.24e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KIT—breast cancer	5.05e-06	6.22e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CG—breast cancer	5.05e-06	6.22e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APC—breast cancer	5.05e-06	6.22e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SERPINE1—breast cancer	5.03e-06	6.19e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA1—breast cancer	5.01e-06	6.16e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—IDH1—breast cancer	5.01e-06	6.16e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPX4—breast cancer	5e-06	6.16e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SULT1A1—breast cancer	5e-06	6.16e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGF—breast cancer	4.99e-06	6.14e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NAT2—breast cancer	4.95e-06	6.09e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CAV1—breast cancer	4.93e-06	6.08e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA1—breast cancer	4.89e-06	6.02e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—IDH1—breast cancer	4.89e-06	6.02e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—breast cancer	4.88e-06	6.01e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	4.88e-06	6.01e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	4.84e-06	5.96e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK3—breast cancer	4.83e-06	5.95e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NAT2—breast cancer	4.83e-06	5.95e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—COMT—breast cancer	4.82e-06	5.94e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—breast cancer	4.8e-06	5.91e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—breast cancer	4.74e-06	5.84e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HMOX1—breast cancer	4.74e-06	5.83e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ITPR1—breast cancer	4.73e-06	5.82e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.71e-06	5.8e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—breast cancer	4.67e-06	5.76e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CD—breast cancer	4.63e-06	5.7e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1—breast cancer	4.62e-06	5.69e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT2—breast cancer	4.62e-06	5.69e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—breast cancer	4.6e-06	5.66e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—breast cancer	4.57e-06	5.63e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—breast cancer	4.55e-06	5.6e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CG—breast cancer	4.49e-06	5.53e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.47e-06	5.51e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TYMS—breast cancer	4.46e-06	5.5e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	4.45e-06	5.48e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CD—breast cancer	4.44e-06	5.46e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—breast cancer	4.41e-06	5.43e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NCOR1—breast cancer	4.41e-06	5.43e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PLA2G4A—breast cancer	4.41e-06	5.43e-05	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—breast cancer	4.39e-06	5.41e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SERPINE1—breast cancer	4.39e-06	5.4e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NOS3—breast cancer	4.37e-06	5.38e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—breast cancer	4.34e-06	5.35e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—DPYD—breast cancer	4.34e-06	5.34e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MED12—breast cancer	4.34e-06	5.34e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—breast cancer	4.31e-06	5.31e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	4.3e-06	5.3e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALDOA—breast cancer	4.27e-06	5.26e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—DPYD—breast cancer	4.24e-06	5.22e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MED12—breast cancer	4.24e-06	5.22e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPX1—breast cancer	4.23e-06	5.2e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOS3—breast cancer	4.19e-06	5.16e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A1—breast cancer	4.18e-06	5.15e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALDOA—breast cancer	4.17e-06	5.13e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ERCC2—breast cancer	4.15e-06	5.11e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOA3—breast cancer	4.15e-06	5.11e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A2—breast cancer	4.12e-06	5.07e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.08e-06	5.02e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOA3—breast cancer	4.05e-06	4.98e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CB—breast cancer	4.04e-06	4.97e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCG2—breast cancer	4.03e-06	4.97e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CPT1A—breast cancer	4.03e-06	4.97e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTR—breast cancer	4.03e-06	4.97e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A2—breast cancer	4.02e-06	4.95e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—breast cancer	4e-06	4.92e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—breast cancer	3.99e-06	4.91e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MDM2—breast cancer	3.97e-06	4.89e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RAF1—breast cancer	3.96e-06	4.88e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HPGDS—breast cancer	3.96e-06	4.87e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CD—breast cancer	3.95e-06	4.86e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RELA—breast cancer	3.94e-06	4.86e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CPT1A—breast cancer	3.94e-06	4.85e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTR—breast cancer	3.94e-06	4.85e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ABCG2—breast cancer	3.94e-06	4.85e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HBA1—breast cancer	3.93e-06	4.84e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—breast cancer	3.92e-06	4.83e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—breast cancer	3.9e-06	4.8e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTHFR—breast cancer	3.9e-06	4.8e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CB—breast cancer	3.87e-06	4.76e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MTOR—breast cancer	3.87e-06	4.76e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HPGDS—breast cancer	3.86e-06	4.76e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HBA1—breast cancer	3.84e-06	4.73e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTT1—breast cancer	3.84e-06	4.73e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ACHE—breast cancer	3.84e-06	4.73e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTT1—breast cancer	3.75e-06	4.61e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ACHE—breast cancer	3.75e-06	4.61e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NOS3—breast cancer	3.73e-06	4.59e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—breast cancer	3.72e-06	4.58e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—breast cancer	3.69e-06	4.55e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.63e-06	4.48e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP17A1—breast cancer	3.63e-06	4.47e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—breast cancer	3.63e-06	4.47e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAV1—breast cancer	3.6e-06	4.43e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS1—breast cancer	3.6e-06	4.43e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ENO1—breast cancer	3.6e-06	4.43e-05	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—breast cancer	3.59e-06	4.42e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.58e-06	4.41e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—breast cancer	3.56e-06	4.38e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—breast cancer	3.55e-06	4.37e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP17A1—breast cancer	3.55e-06	4.37e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.54e-06	4.36e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—breast cancer	3.53e-06	4.35e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2D6—breast cancer	3.53e-06	4.34e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ENO1—breast cancer	3.51e-06	4.32e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS1—breast cancer	3.51e-06	4.32e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—breast cancer	3.49e-06	4.29e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—breast cancer	3.46e-06	4.26e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOA2—breast cancer	3.46e-06	4.26e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUN—breast cancer	3.46e-06	4.25e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CB—breast cancer	3.44e-06	4.24e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2D6—breast cancer	3.44e-06	4.24e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—breast cancer	3.43e-06	4.22e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—breast cancer	3.41e-06	4.2e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOA2—breast cancer	3.38e-06	4.16e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—breast cancer	3.36e-06	4.14e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—FASN—breast cancer	3.36e-06	4.13e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—breast cancer	3.35e-06	4.12e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BCHE—breast cancer	3.34e-06	4.12e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—breast cancer	3.34e-06	4.12e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC5A5—breast cancer	3.3e-06	4.07e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.28e-06	4.04e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CG—breast cancer	3.28e-06	4.03e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—FASN—breast cancer	3.28e-06	4.03e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MAPK3—breast cancer	3.27e-06	4.03e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK8—breast cancer	3.27e-06	4.03e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BCHE—breast cancer	3.26e-06	4.02e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—breast cancer	3.26e-06	4.01e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC5A5—breast cancer	3.22e-06	3.97e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A1—breast cancer	3.19e-06	3.93e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NQO1—breast cancer	3.19e-06	3.93e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—breast cancer	3.18e-06	3.92e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.12e-06	3.85e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NQO1—breast cancer	3.11e-06	3.83e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A1—breast cancer	3.11e-06	3.83e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP3A4—breast cancer	3.11e-06	3.83e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SRC—breast cancer	3.1e-06	3.82e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.09e-06	3.81e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1B1—breast cancer	3.06e-06	3.77e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP3A4—breast cancer	3.04e-06	3.74e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—breast cancer	3.02e-06	3.72e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HSP90AA1—breast cancer	3e-06	3.69e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—breast cancer	2.99e-06	3.68e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1B1—breast cancer	2.98e-06	3.67e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—breast cancer	2.98e-06	3.66e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.97e-06	3.66e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSP90AA1—breast cancer	2.93e-06	3.6e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOA1—breast cancer	2.92e-06	3.59e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CD—breast cancer	2.88e-06	3.55e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—STK11—breast cancer	2.87e-06	3.54e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP19A1—breast cancer	2.87e-06	3.54e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK3—breast cancer	2.86e-06	3.52e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOA1—breast cancer	2.85e-06	3.51e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—breast cancer	2.84e-06	3.5e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—STK11—breast cancer	2.81e-06	3.46e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP19A1—breast cancer	2.81e-06	3.46e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—breast cancer	2.78e-06	3.42e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—breast cancer	2.77e-06	3.41e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NOS3—breast cancer	2.72e-06	3.35e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—breast cancer	2.72e-06	3.35e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.7e-06	3.32e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—COMT—breast cancer	2.67e-06	3.29e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—breast cancer	2.66e-06	3.28e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HMOX1—breast cancer	2.62e-06	3.23e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ITPR1—breast cancer	2.62e-06	3.22e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—COMT—breast cancer	2.61e-06	3.21e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—breast cancer	2.6e-06	3.2e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—breast cancer	2.57e-06	3.16e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HMOX1—breast cancer	2.56e-06	3.15e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ITPR1—breast cancer	2.55e-06	3.15e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—breast cancer	2.52e-06	3.1e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CB—breast cancer	2.51e-06	3.09e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—breast cancer	2.49e-06	3.06e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TYMS—breast cancer	2.47e-06	3.05e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—breast cancer	2.46e-06	3.03e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.44e-06	3.01e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—breast cancer	2.44e-06	3.01e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOR1—breast cancer	2.44e-06	3.01e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TYMS—breast cancer	2.41e-06	2.97e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOR1—breast cancer	2.39e-06	2.94e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLA2G4A—breast cancer	2.39e-06	2.94e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—breast cancer	2.39e-06	2.94e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—breast cancer	2.36e-06	2.9e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPX1—breast cancer	2.34e-06	2.88e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A1—breast cancer	2.32e-06	2.85e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ERCC2—breast cancer	2.3e-06	2.83e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPX1—breast cancer	2.28e-06	2.81e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—breast cancer	2.28e-06	2.81e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A1—breast cancer	2.26e-06	2.79e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ERCC2—breast cancer	2.24e-06	2.76e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—breast cancer	2.21e-06	2.72e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—breast cancer	2.18e-06	2.69e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—breast cancer	2.17e-06	2.67e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTHFR—breast cancer	2.16e-06	2.66e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTHFR—breast cancer	2.11e-06	2.6e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—breast cancer	2.1e-06	2.58e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—breast cancer	2.09e-06	2.57e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—breast cancer	2.01e-06	2.47e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAV1—breast cancer	1.99e-06	2.45e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAV1—breast cancer	1.94e-06	2.39e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—breast cancer	1.93e-06	2.37e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.9e-06	2.34e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CG—breast cancer	1.81e-06	2.24e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CG—breast cancer	1.77e-06	2.18e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—breast cancer	1.71e-06	2.11e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CD—breast cancer	1.6e-06	1.96e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—breast cancer	1.58e-06	1.94e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CD—breast cancer	1.56e-06	1.92e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—breast cancer	1.54e-06	1.89e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—breast cancer	1.53e-06	1.88e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NOS3—breast cancer	1.51e-06	1.86e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NOS3—breast cancer	1.47e-06	1.81e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CB—breast cancer	1.39e-06	1.71e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—breast cancer	1.38e-06	1.7e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CB—breast cancer	1.36e-06	1.67e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—breast cancer	1.34e-06	1.66e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—breast cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—breast cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—breast cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—breast cancer	8.48e-07	1.04e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—breast cancer	8.27e-07	1.02e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—breast cancer	6.93e-07	8.53e-06	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—breast cancer	6.76e-07	8.32e-06	CbGpPWpGaD
